In Europe, commentators have been forecasting consolidation of the dietary supplement industry for some time, but in 2003 acquisitions once again failed to materialize in large numbers—although interest from outside investors and the fragmented nature of things promise deals won’t be far off.
Restraining deal activity were high price expectations. “Owners are still looking out of the rear view mirror at Rexall Sundown, which is unrealistic,” observed Christian Eckel, managing directo
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.